The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
HealthDay on MSN1d
Multiple Sclerosis May Worsen With Menopause TransitionThe menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...
Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...
News Medical on MSN1d
New drug candidate shows potential to restore vision in people with MSResearchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
FOX 9 Minneapolis-St. Paul on MSN1d
Edina, Minnetonka high school basketball rivals team up to ‘beat’ MSThe Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...
The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...
A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...
The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback